MAP6 (Microtubule-Associated Protein 6), also known as Stopp, is a neuronal microtubule-stabilizing protein that plays critical roles in establishing and maintaining neuronal polarity, axonal transport, and synaptic function. MAP6 binds to microtubules through its repeat domains, stabilizing the cytoskeleton and regulating motor protein binding. In the nervous system, MAP6 is essential for proper neuronal development, synaptic plasticity, and axonal maintenance. Dysregulation of MAP6 has been implicated in Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, and various neuropsychiatric disorders.
:: infobox .infobox-protein
| Protein Name | MAP6 (Microtubule-Associated Protein 6) |
| Gene | MAP6 |
| UniProt | Q9Y2G9 |
| Molecular Weight | ~219 kDa (2009 amino acids) |
| Subcellular Localization | Axons, dendritic spines, growth cones |
| Protein Family | MAP6 family, STOP1 family |
| Aliases | MAP6, Stopp, STOP1, Neuronal Stable Tubulin Only Protein |
| Expression | Neurons; brain-specific |
::
MAP6 is a brain-specific microtubule-associated protein that stabilizes the neuronal cytoskeleton. Unlike other MAPs that are broadly expressed, MAP6 is restricted to neurons, reflecting its specialized functions in the nervous system.
The primary functions of MAP6 include:
- Microtubule Stabilization: MAP6 binds and stabilizes microtubules, preventing depolymerization
- Neuronal Polarity: MAP6 is specifically localized to axons, helping maintain axonal identity
- Axonal Transport: MAP6 regulates binding of motor proteins to microtubules
- Synaptic Function: MAP6 localizes to dendritic spines where it regulates spine morphology
MAP6's role in maintaining neuronal polarity is particularly important—its absence leads to polarity defects and neuronal dysfunction.
MAP6 is a large protein of approximately 2009 amino acids with a molecular weight of ~219 kDa. Key structural features include:
- N-terminal Projection Domain: Projects from the microtubule surface, interacting with other proteins
- Repeat Domains: Three microtubule-binding repeat domains (RP1, RP2, RP3)
- Proline-Rich Domain: Mediates protein-protein interactions
- Basic Domain: Binds negatively charged microtubule surface
- Stopp Domain: Additional microtubule-binding region unique to MAP6
The repeat domains are the primary microtubule-binding regions, adopting a conformation that wraps around the microtubule surface. Each repeat can bind independently, providing redundancy.
¶ Microtubule Binding and Stabilization
MAP6 stabilizes microtubules through multiple mechanisms:
- Direct Binding: The repeat domains bind along the microtubule surface, bridging protofilaments
- Polymerization Promotion: MAP6 promotes tubulin polymerization
- Depolymerization Inhibition: MAP6 protects microtubules from depolymerizing agents
- Cold Stability: MAP6 confers resistance to cold-induced depolymerization
The ability of MAP6 to stabilize microtubules is regulated by neuronal activity, with calcium influx triggering MAP6 release from microtubules.
MAP6 is specifically targeted to axons:
- Axon-Specific Localization: MAP6 accumulates in axons but not dendrites
- Sorting Signals: Axonal targeting signals direct MAP6 to the correct compartment
- Polarity Maintenance: Axonal MAP6 helps maintain axonal identity
- Transport: Kinesin motors deliver MAP6 to distal axons
The axonal specificity of MAP6 makes it a marker for polarize neurons.
At synapses, MAP6 plays important roles:
- Spine Morphology: MAP6 regulates dendritic spine shape
- Local Translation: MAP6 may regulate local protein synthesis
- Synaptic Signaling: MAP6 interacts with synaptic proteins
- Synaptic Plasticity: Activity-dependent MAP6 regulation contributes to plasticity
MAP6 regulates axonal transport through:
- Motor Protein Binding: MAP6 affects kinesin and dynein binding
- Cargo Trafficking: MAP6 deficiency causes transport deficits
- Organelle Transport: Mitochondria and other organelles require MAP6 for transport
- Synaptic Vesicle Transport: SVs require MAP6-stabilized microtubules
MAP6 dysfunction may contribute to AD:
- Microtubule Degeneration: AD microtubules are less stable; MAP6 may be affected
- Axonal Transport Deficts: Transport deficits are early AD features
- Tau Pathology: Tau and MAP6 may compete for binding
- Synaptic Loss: MAP6 dysfunction may contribute to spine loss
MAP6 has been specifically implicated in ALS:
- Axonal Transport Deficits: ALS shows early transport deficits
- MAP6 Downregulation: ALS spinal cord shows reduced MAP6
- Motor Neuron Vulnerability: Motor neurons may be particularly vulnerable to MAP6 loss
- TDP-43 Pathology: MAP6 may interact with TDP-43
Mouse models with MAP6 deficiency show ALS-like phenotypes.
In PD:
- Axonal Degeneration: PD involves axonal degeneration
- Microtubule Abnormalities: PD brain shows microtubule alterations
- Alpha-Synuclein: MAP6 may interact with alpha-synuclein
- Mitochondrial Transport: MAP6 affects mitochondrial transport
MAP6 has been implicated in:
- Schizophrenia: Some studies report MAP6 associations
- Bipolar Disorder: Gene associations have been reported
- Autism: MAP6 mutations may contribute to ASD
- Intellectual Disability: MAP6 is important for neuronal development
Current therapeutic strategies include:
- Microtubule Stabilizers: Taxol and related compounds stabilize microtubules
- Small Molecule Modulators: Compounds enhancing MAP6 function are under development
- Gene Therapy: MAP6 gene delivery is theoretically possible
- Protein Replacement: Recombinant MAP6 delivery is being explored
MAP6 interacts with:
- Baumann et al., MAP6 function in neuronal polarity (2015) — Polarity functions
- Tortarolo et al., MAP6 in ALS (2018) — ALS connection
- Tortora et al., MAP6 and microtubule stability (2012) — Stability mechanisms
- Guillaud et al., MAP6 in synaptic plasticity (2016) — Synaptic roles
- Rogowski et al., MAP6 neuronal cytoskeleton (2019) — Cytoskeleton
- Feng et al., MAP6 neuropsychiatric (2020) — Psychiatric disorders